Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00909870 | Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers | PHASE3 | COMPLETED | 537 | — | — | Jun 1, 2009 | Aug 1, 2011 | Jun 17, 2018 | - | — |
| Name | Type | Description |
|---|---|---|
| Dermagraft(R) | DEVICE | Weekly application of Dermagraft(R) with Profore compression as a secondary layer, in combination with systematic surgical wound debridement. |
| Profore | DEVICE | Weekly application of Profore compression dressings, in combination with systematic surgical wound debridement. |